Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#101 / 200 Total
DOGZ - Dogness (International) Corp - Stock Price Chart
CompanyDogness (International) Corp
Market Cap248.24MEPS (ttm)-0.41
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S17.91EPS next 5Y-
P/B2.75EPS Q/Q-300.13%
Dividend-Sales Q/Q-35.81%
Insider Own86.95%Inst Own0.19%
Insider Trans0.00%Inst Trans5.89%
Short Float3.15%Earnings-
Analyst Recom-Target Price-
Avg Volume221.52K52W Range2.79 - 18.35
Dogness (International) Corp. engages in the design and manufacture of pet products, including leashes, and smart products. Its products include leashes, lanyards, ribbon, collars, harnesses ornaments, and specialty products for cats and dogs. The firm produces the products in Classic, Elegance, Luxury, LED, Holiday, Special Function, and Cat series. The company was founded by Shilong Chen in 2003 and is headquartered in Dongguan, China.
NVFY - Nova Lifestyle Inc - Stock Price Chart
CompanyNova Lifestyle Inc
IndustryFurnishings, Fixtures & Appliances
Market Cap4.20MEPS (ttm)-4.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.36EPS next 5Y-
P/B-EPS Q/Q23.28%
Dividend-Sales Q/Q26.77%
Insider Own41.11%Inst Own1.02%
Insider Trans0.00%Inst Trans-11.34%
Short Float2.64%Earnings-
Analyst Recom-Target Price-
Avg Volume1.68M52W Range1.45 - 6.38
Nova Lifestyle, Inc. engages in design, marketing, and manufacture of modern home furniture. The firm offers living room, urban dining, bedroom, and nova qwik products. It sells its products under the brand name Nova and Diamond Sofa. The company was founded by Ya Ming Wong and Yuen Ching Ho in 1992 and is headquartered in Commerce, CA.
MIRM - Mirum Pharmaceuticals Inc - Stock Price Chart
CompanyMirum Pharmaceuticals Inc
Market Cap1.64BEPS (ttm)-3.77
P/E-EPS this Y58.78%
Forward P/E-EPS next Y78.95%
PEG-EPS past 5Y-39.57%
P/S7.33EPS next 5Y-
P/B6.99EPS Q/Q32.64%
Dividend-Sales Q/Q119.07%
Insider Own19.55%Inst Own97.84%
Insider Trans-0.36%Inst Trans11.37%
Short Float23.46%EarningsMay 08/a
Analyst Recom1.09Target Price56.36
Avg Volume596.03K52W Range23.14 - 35.56
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ramasastry SairaDirectorJun 05 '24Option Exercise14.125,00070,6005,000Jun 07 06:20 PM
Ramasastry SairaDirectorJun 05 '24Sale25.685,000128,4000Jun 07 06:20 PM
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 27 '24Buy24.802,00049,60014,000Mar 27 08:47 PM
Radovich PeterPRESIDENT AND COOMar 25 '24Sale25.804,303111,01729,013Mar 25 05:41 PM
BJERKHOLT ERICCHIEF FINANCIAL OFFICERMar 18 '24Buy25.802,00051,60012,000Mar 18 05:34 PM
CRBU - Caribou Biosciences Inc - Stock Price Chart
CompanyCaribou Biosciences Inc
Market Cap168.90MEPS (ttm)-1.45
P/E-EPS this Y-33.40%
Forward P/E-EPS next Y-13.39%
PEG-EPS past 5Y-37.16%
P/S5.06EPS next 5Y14.50%
P/B0.49EPS Q/Q-0.74%
Dividend-Sales Q/Q-30.64%
Insider Own11.55%Inst Own74.89%
Insider Trans0.00%Inst Trans8.97%
Short Float14.41%EarningsMay 07/a
Analyst Recom1.44Target Price16.62
Avg Volume2.31M52W Range1.60 - 8.59
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kanner StevenChief Scientific OfficerFeb 06 '24Option Exercise2.6930,57782,252354,037Feb 08 05:06 PM
SHOT - Safety Shot Inc - Stock Price Chart
CompanySafety Shot Inc
IndustryBeverages - Non-Alcoholic
Market Cap59.02MEPS (ttm)-0.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-43.19%
P/S22.02EPS next 5Y-
P/B10.07EPS Q/Q-545.31%
Dividend-Sales Q/Q-84.78%
Insider Own24.28%Inst Own9.93%
Insider Trans0.04%Inst Trans0.68%
Short Float8.21%Earnings-
Analyst Recom1.00Target Price2.76
Avg Volume832.13K52W Range0.26 - 7.50
Safety Shot, Inc. engages in the business of developing cannabidiol (CBD) based medical therapeutics and wellness products. It operates under the Sales and Development of CBD Based Skin Care and Therapeutic Products, and Sales and Merchandise Sold to Theme Parks segments. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Safety Shot, Inc.10% OwnerJun 07 '24Sale1.1220,00022,4003,980,000Jun 10 04:30 PM
Gulyas JohnDirectorDec 28 '23Buy3.882,5009,7001,687,166Jan 02 07:46 AM
Gulyas JohnDirectorDec 28 '23Buy3.882,5009,7001,687,166Dec 28 04:05 PM
PXDT - Pixie Dust Technologies Inc ADR - Stock Price Chart
CompanyPixie Dust Technologies Inc ADR
IndustryConsumer Electronics
Market Cap22.34MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.54EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.52%
Insider Trans-Inst Trans-
Short Float-EarningsFeb 13/a
Analyst Recom1.00Target Price5.24
Avg Volume12.32K52W Range1.40 - 10.51
Pixie Dust Technologies, Inc. engages in providing consumer personal care products and spatial materials through the utilization of mechanobiology and metamaterials. It operates through Personal Care and Diversity, and Workspace and Digital Transformation divisions. The Personal Care and Diversity division develops technologies to enhance personal care and quality of life. The Workspace and Digital Transformation division develops technologies for sensing and controlling space. The company was founded by Yoichi Ochiai, Takayuki Hoshi and Taiichiro Murakami on May 10, 2017 and is headquartered in Tokyo, Japan.
CISS - C3is Inc - Stock Price Chart
CompanyC3is Inc
IndustryMarine Shipping
Market Cap8.15MEPS (ttm)162.76
P/E0.01EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.21EPS next 5Y-
P/B0.04EPS Q/Q-76.34%
Dividend-Sales Q/Q305.86%
Insider Own23.08%Inst Own2.43%
Insider Trans0.00%Inst Trans-
Short Float32.20%EarningsMay 28/b
Analyst Recom-Target Price-
Avg Volume2.02M52W Range1.11 - 520.00
C3is, Inc. is a holding company that engages in the provision of seaborne transportation services to dry bulk charterers through its subsidiaries. It offers services to dry bulk charterers such as national and private industrial users, commodity producers, and commodity traders. The company was founded on July 25, 2022 and is headquartered in Athens, Greece.
IFRX - InflaRx N.V. - Stock Price Chart
CompanyInflaRx N.V.
Market Cap98.33MEPS (ttm)-0.76
P/E-EPS this Y4.72%
Forward P/E-EPS next Y-15.88%
PEG-EPS past 5Y9.74%
P/S893.91EPS next 5Y-
P/B0.96EPS Q/Q32.98%
Dividend-Sales Q/Q-
Insider Own17.08%Inst Own23.53%
Insider Trans0.00%Inst Trans-18.47%
Short Float0.06%EarningsMay 08/b
Analyst Recom1.40Target Price8.06
Avg Volume195.63K52W Range1.14 - 4.62
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
PDSB - PDS Biotechnology Corporation - Stock Price Chart
CompanyPDS Biotechnology Corporation
Market Cap104.90MEPS (ttm)-1.37
P/E-EPS this Y7.43%
Forward P/E-EPS next Y-7.25%
PEG-EPS past 5Y42.97%
P/S-EPS next 5Y-
P/B2.82EPS Q/Q4.06%
Dividend-Sales Q/Q-
Insider Own4.17%Inst Own20.49%
Insider Trans0.00%Inst Trans-2.52%
Short Float19.09%EarningsMay 15/b
Analyst Recom1.00Target Price12.00
Avg Volume777.83K52W Range2.53 - 6.85
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
PLCE - Childrens Place Inc - Stock Price Chart
CompanyChildrens Place Inc
IndustryApparel Retail
Market Cap109.56MEPS (ttm)-13.02
P/E-EPS this Y95.78%
Forward P/E9.95EPS next Y348.38%
PEG-EPS past 5Y-
P/S0.07EPS next 5Y-7.10%
P/B-EPS Q/Q-28.29%
Dividend-Sales Q/Q-16.71%
Insider Own60.38%Inst Own46.41%
Insider Trans133.11%Inst Trans-8.54%
Short Float53.77%EarningsJun 12/a
Analyst Recom3.00Target Price12.00
Avg Volume1.17M52W Range6.58 - 38.03
The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children's Place, Baby Place, and Gymboree. It operates through The Children's Place U.S. and The Children's Place International segments. The Children's Place U.S. segment refers to the company's U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children's Place International segment is involved in the Canadian-based stores, revenue from the company's Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mithaq Capital SPC10% OwnerFeb 13 '24Buy11.15966,34410,779,0276,751,387Feb 15 03:57 PM
Mithaq Capital SPC10% OwnerFeb 12 '24Buy15.801,566,47524,749,5254,663,743Feb 14 07:51 PM
Mithaq Capital SPC10% OwnerFeb 09 '24Buy11.021,849,39720,387,1783,097,268Feb 13 09:11 PM
ELFERS JANE TPresident and CEOJul 05 '23Buy23.7043,0001,019,100370,033Jul 06 08:30 AM